{"transactions":[{"id":742945,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2026-06-10T20:40:15.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":5853,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock option was granted on June 9, 2026, and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":5853,"derivative":{"exercise_price":28.78,"expiration_date":"2036-06-08","underlying":"Common Stock","underlying_shares":5853},"source":{"system":"sec-edgar","filing":"0001628280-26-042260","document":"wk-form4_1781124012.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828026042260/wk-form4_1781124012.xml","form_type":"4"}},{"id":742944,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-10T20:40:15.000Z","date":"2026-06-09","kind":"grant","planned":false,"acquired":true,"shares":3315,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year\nanniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":866474,"source":{"system":"sec-edgar","filing":"0001628280-26-042260","document":"wk-form4_1781124012.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828026042260/wk-form4_1781124012.xml","form_type":"4"}},{"id":850719,"issuer":{"id":5246,"kind":"organization","name":"SS Innovations International, Inc.","symbol":"SSII"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2026-03-10T22:05:34.000Z","date":"2026-03-06","kind":"purchase","planned":false,"acquired":true,"shares":501253,"price":3.99,"value":1999999.47,"ownership":{"direct":true},"balance_after":10775485,"source":{"system":"sec-edgar","filing":"0001213900-26-025795","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000121390026025795/ownership.xml","form_type":"4"}},{"id":1066271,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-14T20:18:26.000Z","date":"2025-08-13","kind":"purchase","planned":false,"acquired":true,"shares":20000,"price":39.2569,"value":785138.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were bought in multiple transactions at prices ranging from $38.71 to $39.645, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares bought at each separate price within the ranges set forth in this footnote."}],"balance_after":863159,"source":{"system":"sec-edgar","filing":"0001628280-25-040397","document":"wk-form4_1755202701.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828025040397/wk-form4_1755202701.xml","form_type":"4"}},{"id":1113112,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-06-12T20:27:36.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":2771,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock option was granted on June 10, 2025 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":2771,"derivative":{"exercise_price":64.23,"expiration_date":"2035-06-09","underlying":"Common Stock","underlying_shares":2771},"source":{"system":"sec-edgar","filing":"0001628280-25-030996","document":"wk-form4_1749760050.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828025030996/wk-form4_1749760050.xml","form_type":"4"}},{"id":1113111,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-12T20:27:36.000Z","date":"2025-06-10","kind":"grant","planned":false,"acquired":true,"shares":1538,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":843159,"source":{"system":"sec-edgar","filing":"0001628280-25-030996","document":"wk-form4_1749760050.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828025030996/wk-form4_1749760050.xml","form_type":"4"}},{"id":1249251,"issuer":{"id":5246,"kind":"organization","name":"SS Innovations International, Inc.","symbol":"SSII"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-02-24T22:00:11.000Z","date":"2025-02-20","kind":"purchase","planned":false,"acquired":true,"shares":3645224,"price":1.372,"value":5001247.328,"ownership":{"direct":false,"nature":"Held by Frederic Hutchins Moll Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person has a 100% interest in the Frederic Hutchins Moll Revocable Trust which holds the shares of SSII covered by this report."}],"balance_after":10060813,"source":{"system":"sec-edgar","filing":"0001213900-25-016651","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000121390025016651/ownership.xml","form_type":"4"}},{"id":1271339,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-12T22:39:47.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":5263,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":0.86,"expiration_date":"2025-02-16","underlying":"Common Stock","underlying_shares":5263},"source":{"system":"sec-edgar","filing":"0001628280-25-005209","document":"wk-form4_1739399980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828025005209/wk-form4_1739399980.xml","form_type":"4"}},{"id":1271338,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2025-02-12T22:39:47.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":false,"shares":26749,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Stock option is fully vested and exercisable."}],"balance_after":0,"derivative":{"exercise_price":1.33,"expiration_date":"2025-09-17","underlying":"Common Stock","underlying_shares":26749},"source":{"system":"sec-edgar","filing":"0001628280-25-005209","document":"wk-form4_1739399980.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828025005209/wk-form4_1739399980.xml","form_type":"4"}},{"id":1271337,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-12T22:39:47.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":5263,"price":0.86,"value":4526.18,"ownership":{"direct":true},"balance_after":841621,"source":{"system":"sec-edgar","filing":"0001628280-25-005209","document":"wk-form4_1739399980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828025005209/wk-form4_1739399980.xml","form_type":"4"}},{"id":1271336,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-02-12T22:39:47.000Z","date":"2025-02-10","kind":"exercise","planned":false,"acquired":true,"shares":26749,"price":1.33,"value":35576.17,"ownership":{"direct":true},"balance_after":836358,"source":{"system":"sec-edgar","filing":"0001628280-25-005209","document":"wk-form4_1739399980.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828025005209/wk-form4_1739399980.xml","form_type":"4"}},{"id":1305015,"issuer":{"id":5246,"kind":"organization","name":"SS Innovations International, Inc.","symbol":"SSII"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-01-10T21:20:21.000Z","date":"2025-01-09","kind":"purchase","planned":false,"acquired":true,"shares":1457726,"price":1.372,"value":2000000.072,"ownership":{"direct":false,"nature":"Held by Sonder Futures II, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The Reporting Person is a member of the general partner of Sonder Futures II, L.P. which holds the shares covered by this report. Together with the other members of the general partner of Sonder Futures II, L.P., the reporting person has shared voting and dispositive power over the shares covered by this report."}],"balance_after":1457726,"source":{"system":"sec-edgar","filing":"0001213900-25-002667","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000121390025002667/ownership.xml","form_type":"4"}},{"id":1314098,"issuer":{"id":5246,"kind":"organization","name":"SS Innovations International, Inc.","symbol":"SSII"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2025-01-03T22:00:14.000Z","date":"2024-12-31","kind":"purchase","planned":false,"acquired":true,"shares":2186589,"price":1.372,"value":3000000.108,"ownership":{"direct":false,"nature":"Held by Frederic Hutchins Moll Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person has a 100% interest in the Frederic Hutchins Moll Revocable Trust which holds the shares of SSII covered by this report."}],"balance_after":6415589,"source":{"system":"sec-edgar","filing":"0001213900-25-000831","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000121390025000831/ownership.xml","form_type":"4"}},{"id":1349089,"issuer":{"id":5246,"kind":"organization","name":"SS Innovations International, Inc.","symbol":"SSII"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2024-11-27T22:00:11.000Z","date":"2024-11-25","kind":"purchase","planned":false,"acquired":true,"shares":3644315,"price":1.372,"value":5000000.18,"ownership":{"direct":false,"nature":"Held by Frederic Hutchins Moll Revocable Trust"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"The reporting person has a 100% interest in the Frederic Hutchins Moll Revocable Trust which holds the shares of SSII covered by this report."}],"balance_after":4229000,"source":{"system":"sec-edgar","filing":"0001213900-24-103553","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000121390024103553/ownership.xml","form_type":"4"}},{"id":1488208,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-06T20:25:46.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":2526,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option was granted on June 4, 2024 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":2526,"derivative":{"exercise_price":67.29,"expiration_date":"2034-06-03","underlying":"Common Stock","underlying_shares":2526},"source":{"system":"sec-edgar","filing":"0001628280-24-027040","document":"wk-form4_1717705537.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828024027040/wk-form4_1717705537.xml","form_type":"4"}},{"id":1488207,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-06T20:25:46.000Z","date":"2024-06-04","kind":"grant","planned":false,"acquired":true,"shares":1376,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":809609,"source":{"system":"sec-edgar","filing":"0001628280-24-027040","document":"wk-form4_1717705537.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828024027040/wk-form4_1717705537.xml","form_type":"4"}},{"id":1496455,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-31T20:41:41.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":16393,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":2.196,"expiration_date":"2025-06-16","underlying":"Common Stock","underlying_shares":16393},"source":{"system":"sec-edgar","filing":"0001642545-24-000121","document":"wk-form4_1717188091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000121/wk-form4_1717188091.xml","form_type":"4"}},{"id":1496454,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-05-31T20:41:41.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":17381,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Pursuant to the Merger Agreement, at the Effective Time, each option to purchase shares of Common Stock (\"Company Option\") that was outstanding and unexercised as of immediately prior to the Effective Time, whether vested or unvested, with a per share exercise price that was less than the Merger Consideration, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such Company Option immediately prior to the Effective Time, and (ii) the excess of (A) the Merger Consideration over (B) the per share exercise price of such Company Option."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":17381},"source":{"system":"sec-edgar","filing":"0001642545-24-000121","document":"wk-form4_1717188091.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000121/wk-form4_1717188091.xml","form_type":"4"}},{"id":1496453,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-05-31T20:41:41.000Z","date":"2024-05-31","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":287521,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This Form 4 reports the disposition of securities pursuant to the terms of the Agreement and Plan of Merger (the \"Merger Agreement\"), dated as of April 4, 2024, by and among the Issuer, Johnson & Johnson (\"J&J\"), and Sweep Merger Sub, Inc., a wholly owned subsidiary of J&J (\"Merger Sub\"), pursuant to which Merger Sub merged with and into the Issuer (the \"Merger\"), effective as of the effective time of the Merger (the \"Effective Time\"), with the Issuer surviving the Merger as a wholly owned subsidiary of J&J. As a result of the Merger, at the Effective Time, each outstanding share of common stock, par value $0.001 per share, of the Issuer (\"Common Stock\") outstanding immediately prior to the Effective Time (excluding Excluded Shares and any Dissenting Company Shares, each as defined in the Merger Agreement) was automatically converted into the right to receive $335.00 in cash (the \"Merger Consideration\"),"},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"(Continued from Footnote 1) without interest and less any applicable withholding taxes.  Additionally, pursuant to the Merger Agreement, at the Effective Time, each restricted stock unit (\"RSU\") outstanding immediately prior to the Effective Time, whether vested or unvested, was cancelled and converted into the right to receive a cash amount, without interest and less any applicable withholding taxes, equal to the product of (i) the aggregate number of shares of Common Stock underlying such RSU immediately prior to the Effective Time and (ii) the Merger Consideration."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001642545-24-000121","document":"wk-form4_1717188091.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000121/wk-form4_1717188091.xml","form_type":"4"}},{"id":1625045,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-23T01:15:02.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":1200,"price":261.96,"value":314352.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $261.54 to $262.40. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":287521,"source":{"system":"sec-edgar","filing":"0001642545-24-000055","document":"wk-form4_1708650890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000055/wk-form4_1708650890.xml","form_type":"4"}},{"id":1625044,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-23T01:15:02.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":4890,"price":260.8,"value":1275312.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $260.45 to $261.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":288721,"source":{"system":"sec-edgar","filing":"0001642545-24-000055","document":"wk-form4_1708650890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000055/wk-form4_1708650890.xml","form_type":"4"}},{"id":1625043,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-23T01:15:02.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":5528,"price":259.91,"value":1436782.48,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $259.44 to $260.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":293611,"source":{"system":"sec-edgar","filing":"0001642545-24-000055","document":"wk-form4_1708650890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000055/wk-form4_1708650890.xml","form_type":"4"}},{"id":1625042,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-23T01:15:02.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":2660,"price":258.95,"value":688807.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $258.43 to $259.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":299139,"source":{"system":"sec-edgar","filing":"0001642545-24-000055","document":"wk-form4_1708650890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000055/wk-form4_1708650890.xml","form_type":"4"}},{"id":1625041,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-23T01:15:02.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":8649,"price":258.09,"value":2232220.41,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $257.43 to $258.39. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":301799,"source":{"system":"sec-edgar","filing":"0001642545-24-000055","document":"wk-form4_1708650890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000055/wk-form4_1708650890.xml","form_type":"4"}},{"id":1625040,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-23T01:15:02.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":14165,"price":256.82,"value":3637855.3,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $256.43 to $257.29. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":310448,"source":{"system":"sec-edgar","filing":"0001642545-24-000055","document":"wk-form4_1708650890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000055/wk-form4_1708650890.xml","form_type":"4"}},{"id":1625039,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-23T01:15:02.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":16464,"price":255.95,"value":4213960.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $255.43 to $256.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":324613,"source":{"system":"sec-edgar","filing":"0001642545-24-000055","document":"wk-form4_1708650890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000055/wk-form4_1708650890.xml","form_type":"4"}},{"id":1625038,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-23T01:15:02.000Z","date":"2024-02-21","kind":"sale","planned":false,"acquired":false,"shares":6444,"price":255.14,"value":1644122.16,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $254.43 to $255.42. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":341077,"source":{"system":"sec-edgar","filing":"0001642545-24-000055","document":"wk-form4_1708650890.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000055/wk-form4_1708650890.xml","form_type":"4"}},{"id":1651400,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2024-02-10T01:07:36.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":false,"shares":81967,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.61,"expiration_date":"2024-02-24","underlying":"Common Stock","underlying_shares":81967},"source":{"system":"sec-edgar","filing":"0001642545-24-000042","document":"wk-form4_1707527245.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000042/wk-form4_1707527245.xml","form_type":"4"}},{"id":1651399,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-02-10T01:07:36.000Z","date":"2024-02-08","kind":"exercise","planned":false,"acquired":true,"shares":81967,"price":0.61,"value":49999.87,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"The total reported in Column 5 of Table I includes 33,960 shares of the issuer's common stock previously held by MBL-2 Holdings LLC (the \"LLC\"), which were previously distributed, for no consideration, to the reporting person's direct ownership in a transaction exempt from reporting pursuant to Rule 16a-13.  The reporting person is the sole managing member of the LLC."}],"balance_after":347521,"source":{"system":"sec-edgar","filing":"0001642545-24-000042","document":"wk-form4_1707527245.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000164254524000042/wk-form4_1707527245.xml","form_type":"4"}},{"id":1717669,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T22:33:03.000Z","date":"2023-12-06","kind":"sale","planned":false,"acquired":false,"shares":27242,"price":39.2467,"value":1069158.6014,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.180 to $40.1799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":808233,"source":{"system":"sec-edgar","filing":"0001628280-23-041163","document":"wk-form4_1702074773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828023041163/wk-form4_1702074773.xml","form_type":"4"}},{"id":1717668,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-12-08T22:33:03.000Z","date":"2023-12-06","kind":"sale","planned":false,"acquired":false,"shares":51758,"price":38.4906,"value":1992196.4748,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.1800 to $39.1799, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote."}],"balance_after":835475,"source":{"system":"sec-edgar","filing":"0001628280-23-041163","document":"wk-form4_1702074773.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828023041163/wk-form4_1702074773.xml","form_type":"4"}},{"id":1851839,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-16T20:52:49.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":4865,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock Option was granted on June 15, 2023 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":4865,"derivative":{"exercise_price":35.09,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":4865},"source":{"system":"sec-edgar","filing":"0001628280-23-022502","document":"wk-form4_1686948758.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828023022502/wk-form4_1686948758.xml","form_type":"4"}},{"id":1851838,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-16T20:52:49.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":2711,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":887233,"source":{"system":"sec-edgar","filing":"0001628280-23-022502","document":"wk-form4_1686948758.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828023022502/wk-form4_1686948758.xml","form_type":"4"}},{"id":1854099,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-06-15T22:50:28.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":736,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":231594,"source":{"system":"sec-edgar","filing":"0001209191-23-037556","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000120919123037556/doc4.xml","form_type":"4"}},{"id":2015755,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T02:05:00.000Z","date":"2022-09-02","kind":"gift","acquired":false,"shares":33960,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F4","text":"This transaction represents a contribution, for no consideration, of shares of the issuer's common stock to MBL-2 Holdings LLC, of which the reporting person is the sole managing member."}],"balance_after":230858,"source":{"system":"sec-edgar","filing":"0001209191-23-009585","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000120919123009585/doc5.xml","form_type":"5"}},{"id":2015754,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T02:05:00.000Z","date":"2022-09-01","kind":"gift","acquired":false,"shares":9300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This transaction represents a gift of stock by the reporting person to the LVM 2022 Trust (the \"Trust\"), which is an irrevocable trust established for the benefit of one of his adult children. The reporting person is neither a trustee nor a beneficiary and he disclaims beneficial ownership of all securities owned by the Trust."}],"balance_after":264818,"source":{"system":"sec-edgar","filing":"0001209191-23-009585","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000120919123009585/doc5.xml","form_type":"5"}},{"id":2015753,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T02:05:00.000Z","date":"2022-09-01","kind":"gift","acquired":false,"shares":9300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"This transaction represents a gift of stock by the reporting person to one of his adult children."}],"balance_after":274118,"source":{"system":"sec-edgar","filing":"0001209191-23-009585","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000120919123009585/doc5.xml","form_type":"5"}},{"id":2015752,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2023-02-15T02:05:00.000Z","date":"2022-09-01","kind":"gift","acquired":false,"shares":9300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction represents a gift of stock by the reporting person to one of his adult children."}],"balance_after":283418,"source":{"system":"sec-edgar","filing":"0001209191-23-009585","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000120919123009585/doc5.xml","form_type":"5"}},{"id":2221042,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-27T23:56:47.000Z","date":"2022-06-23","kind":"grant","acquired":true,"shares":994,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":292718,"source":{"system":"sec-edgar","filing":"0001209191-22-039542","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000120919122039542/doc4.xml","form_type":"4"}},{"id":2237516,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T20:15:22.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":4205,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The Stock option was granted on June 7, 2022 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Stock option was granted on June 7, 2022 and vests in full on the earlier to occur of (i) the one-year anniversary of the grant date, or (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":4205,"derivative":{"exercise_price":38.85,"expiration_date":"2032-06-06","underlying":"Common Stock","underlying_shares":4205},"source":{"system":"sec-edgar","filing":"0001628280-22-016689","document":"wf-form4_165480570069698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828022016689/wf-form4_165480570069698.xml","form_type":"4"}},{"id":2237515,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2022-06-09T20:15:22.000Z","date":"2022-06-07","kind":"grant","acquired":true,"shares":2001,"price":37.48,"value":74997.48,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. The securities shall vest in full on the earlier to occur of (i) the one-year anniversary of the grant date, and (ii) the date of the next annual meeting following the grant date, subject to continued service through the applicable vesting date."}],"balance_after":884522,"source":{"system":"sec-edgar","filing":"0001628280-22-016689","document":"wf-form4_165480570069698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828022016689/wf-form4_165480570069698.xml","form_type":"4"}},{"id":2490392,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option","published_at":"2021-12-01T22:29:22.000Z","date":"2021-11-30","kind":"exercise","acquired":false,"shares":12295,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Twenty-five percent of the shares subject to the option vested on 6/21/2012 and the balance of the shares vested in equal monthly installments thereafter for 36 months."}],"balance_after":0,"derivative":{"exercise_price":0.488,"expiration_date":"2021-12-09","underlying":"Common Stock","underlying_shares":12295},"source":{"system":"sec-edgar","filing":"0001209191-21-067315","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000120919121067315/doc4.xml","form_type":"4"}},{"id":2490391,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-12-01T22:29:22.000Z","date":"2021-11-30","kind":"exercise","acquired":true,"shares":12295,"price":0.488,"value":5999.96,"ownership":{"direct":true},"balance_after":291724,"source":{"system":"sec-edgar","filing":"0001209191-21-067315","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000120919121067315/doc4.xml","form_type":"4"}},{"id":2562951,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series G Convertible Preferred Stock","published_at":"2021-09-21T22:34:49.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":60172,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":60172},"source":{"system":"sec-edgar","filing":"0001628280-21-018954","document":"wf-form4_163226367108643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828021018954/wf-form4_163226367108643.xml","form_type":"4"}},{"id":2562950,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series F Convertible Preferred Stock","published_at":"2021-09-21T22:34:49.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":16974,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":16974},"source":{"system":"sec-edgar","filing":"0001628280-21-018954","document":"wf-form4_163226367108643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828021018954/wf-form4_163226367108643.xml","form_type":"4"}},{"id":2562949,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series E Convertible Preferred Stock","published_at":"2021-09-21T22:34:49.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":9104,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":9104},"source":{"system":"sec-edgar","filing":"0001628280-21-018954","document":"wf-form4_163226367108643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828021018954/wf-form4_163226367108643.xml","form_type":"4"}},{"id":2562948,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Convertible Preferred Stock","published_at":"2021-09-21T22:34:49.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":108214,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":108214},"source":{"system":"sec-edgar","filing":"0001628280-21-018954","document":"wf-form4_163226367108643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828021018954/wf-form4_163226367108643.xml","form_type":"4"}},{"id":2562947,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2021-09-21T22:34:49.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":89840,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":89840},"source":{"system":"sec-edgar","filing":"0001628280-21-018954","document":"wf-form4_163226367108643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828021018954/wf-form4_163226367108643.xml","form_type":"4"}},{"id":2562946,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2021-09-21T22:34:49.000Z","date":"2021-09-17","kind":"exercise","acquired":false,"shares":45586,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":45586},"source":{"system":"sec-edgar","filing":"0001628280-21-018954","document":"wf-form4_163226367108643.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828021018954/wf-form4_163226367108643.xml","form_type":"4"}},{"id":2562945,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-21T22:34:49.000Z","date":"2021-09-17","kind":"purchase","acquired":true,"shares":400000,"price":25,"value":10000000.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents a purchase in the Issuer's public offering."}],"balance_after":882521,"source":{"system":"sec-edgar","filing":"0001628280-21-018954","document":"wf-form4_163226367108643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828021018954/wf-form4_163226367108643.xml","form_type":"4"}},{"id":2562944,"issuer":{"id":4831,"kind":"organization","name":"PROCEPT BioRobotics Corp","symbol":"PRCT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-09-21T22:34:49.000Z","date":"2021-09-17","kind":"exercise","acquired":true,"shares":329890,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock, Series B Preferred Stock, Series C Preferred Stock, Series D Preferred Stock, Series E Preferred Stock, Series F Preferred Stock and Series G Preferred Stock converted automatically into one share of Common Stock upon the closing of the Issuer's initial public offering. These shares have no expiration date."}],"balance_after":482521,"source":{"system":"sec-edgar","filing":"0001628280-21-018954","document":"wf-form4_163226367108643.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000162828021018954/wf-form4_163226367108643.xml","form_type":"4"}},{"id":2635987,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-07-12T22:52:13.000Z","date":"2021-06-28","kind":"grant","acquired":true,"shares":850,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock. The shares subject to the restricted stock units vest on 6/25/2022, subject to the Reporting Person's continued service through such date."}],"balance_after":279429,"source":{"system":"sec-edgar","filing":"0000950103-21-010361","document":"dp154197_4-moll.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010321010361/dp154197_4-moll.xml","form_type":"4"}},{"id":2876482,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-02-05T18:53:17.000Z","date":"2021-01-19","kind":"exercise","acquired":false,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The vesting commencement date of the option is February 1, 2011. 7500 shares subject to the option vested on February 2, 2011 and 1/60th of the shares subject to the option vested monthly thereafter over 24 months."}],"balance_after":0,"derivative":{"exercise_price":0.72,"expiration_date":"2021-01-31","underlying":"Common Stock","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001562180-21-000955","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218021000955/primarydocument.xml","form_type":"4"}},{"id":2876481,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-02-05T18:53:17.000Z","date":"2021-01-19","kind":"exercise","acquired":true,"shares":12500,"price":0.72,"value":9000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 5,011 restricted stock units."}],"balance_after":260961,"source":{"system":"sec-edgar","filing":"0001562180-21-000955","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218021000955/primarydocument.xml","form_type":"4"}},{"id":3078660,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-22T00:36:16.000Z","date":"2020-07-17","kind":"grant","acquired":true,"shares":2701,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":278579,"source":{"system":"sec-edgar","filing":"0000950103-20-014014","document":"dp132624_4-moll.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010320014014/dp132624_4-moll.xml","form_type":"4"}},{"id":3118430,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-06-08T16:52:42.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":9666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 4, 2020."}],"balance_after":9666,"derivative":{"exercise_price":11.84,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":9666},"source":{"system":"sec-edgar","filing":"0001562180-20-004319","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020004319/primarydocument.xml","form_type":"4"}},{"id":3118429,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-06-08T16:52:42.000Z","date":"2020-06-04","kind":"grant","acquired":true,"shares":5011,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan. Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting. The restricted stock units vest one year from grant date on June 4, 2021."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 5,011 restricted stock units."}],"balance_after":248461,"source":{"system":"sec-edgar","filing":"0001562180-20-004319","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020004319/primarydocument.xml","form_type":"4"}},{"id":3305171,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-01-22T17:02:55.000Z","date":"2020-01-17","kind":"grant","acquired":true,"shares":3355,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments commencing on January 1, 2020."}],"balance_after":3355,"derivative":{"exercise_price":24.45,"expiration_date":"2030-01-16","underlying":"Common Stock","underlying_shares":3355},"source":{"system":"sec-edgar","filing":"0001562180-20-000477","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218020000477/primarydocument.xml","form_type":"4"}},{"id":3377520,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Unsecured Subordinated Convertible Promissory Note","published_at":"2019-11-08T01:35:15.000Z","date":"2019-11-07","kind":"exercise","acquired":false,"price":0,"reported_value":2000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664, which conversion occurred prior to the 1-for 15 reverse stock split that occurred on November 7, 2019."},{"field":"reported_value","element":"transactionTotalValue","label":"F8","text":"Through the date of conversion, the principal and interest under this Unsecured Subordinated Convertible Promissory Note, totaled $2,034,191.85 which total was converted into shares of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This Unsecured Subordinated Convertible Promissory Note converted upon the consumation of the Merger, pursuant to its terms."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F5","text":"This Unsecured Subordinated Convertible Promissory Note was previously reported as covering 4,288,164 shares which conversion shares were adjusted to account for interest due thereon and reflect the 1-for-15 reverse stock split that occurred after the conversion on November 7, 2019."}],"balance_after":0,"derivative":{"expiration_date":"2020-08-28","underlying":"Common Stock","underlying_shares":290765},"source":{"system":"sec-edgar","filing":"0001382963-19-000115","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000138296319000115/edgar.xml","form_type":"4"}},{"id":3377519,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Unsecured Subordinated Convertible Promissory Note","published_at":"2019-11-08T01:35:15.000Z","date":"2019-11-07","kind":"exercise","acquired":false,"price":0,"reported_value":3000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664, which conversion occurred prior to the 1-for 15 reverse stock split that occurred on November 7, 2019."},{"field":"reported_value","element":"transactionTotalValue","label":"F6","text":"Through the date of conversion, the principal and interest under this Unsecured Subordinated Convertible Promissory Note, totaled $3,165,041.10 which total was converted into shares of common stock of the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"This Unsecured Subordinated Convertible Promissory Note converted upon the consumation of the Merger, pursuant to its terms."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F3","text":"This Unsecured Subordinated Convertible Promissory Note was previously reported as covering 6,432,246 shares which conversion shares were adjusted to account for interest due thereon and reflect the 1-for-15 reverse stock split that occurred after the conversion on November 7, 2019."}],"balance_after":0,"derivative":{"expiration_date":"2020-08-28","underlying":"Common Stock","underlying_shares":452407},"source":{"system":"sec-edgar","filing":"0001382963-19-000115","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000138296319000115/edgar.xml","form_type":"4"}},{"id":3377518,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T01:35:15.000Z","date":"2019-11-07","kind":"exercise","acquired":true,"shares":290765,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"This Unsecured Subordinated Convertible Promissory Note was previously reported as covering 4,288,164 shares which conversion shares were adjusted to account for interest due thereon and reflect the 1-for-15 reverse stock split that occurred after the conversion on November 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664, which conversion occurred prior to the 1-for 15 reverse stock split that occurred on November 7, 2019."}],"balance_after":950553,"source":{"system":"sec-edgar","filing":"0001382963-19-000115","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000138296319000115/edgar.xml","form_type":"4"}},{"id":3377517,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T01:35:15.000Z","date":"2019-11-07","kind":"exercise","acquired":true,"shares":452407,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"This Unsecured Subordinated Convertible Promissory Note was previously reported as covering 6,432,246 shares which conversion shares were adjusted to account for interest due thereon and reflect the 1-for-15 reverse stock split that occurred after the conversion on November 7, 2019."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This Unsecured Subordinated Convertible Promissory Note was converted with a conversion price of $0.4664, which conversion occurred prior to the 1-for 15 reverse stock split that occurred on November 7, 2019."}],"balance_after":659788,"source":{"system":"sec-edgar","filing":"0001382963-19-000115","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000138296319000115/edgar.xml","form_type":"4"}},{"id":3377516,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-11-08T01:35:15.000Z","date":"2019-11-07","kind":"grant","acquired":true,"shares":145394,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Received in connection with the Merger, upon the conversion of the outstanidng principal and any accrued and unpaid interest of two 8% Convertible Promissory Notes issued by Venus Concept Ltd., dated as of August 14, 2019 and August 21, 2019, in the original principal amounts of $197,142.85 and $802,857.15, respectively."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Dr. Moll's previously reported holdings of common stock of the Issuer of 929,809 shares was adjusted to reflect the Issuer's 1-for-15 reverse stock split that occurred on November 7, 2019, which resulted in Dr. Moll's ownership of 867,822 less shares of common stock."}],"balance_after":207381,"source":{"system":"sec-edgar","filing":"0001382963-19-000115","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000138296319000115/edgar.xml","form_type":"4"}},{"id":3395419,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-09T22:19:37.000Z","date":"2019-10-07","kind":"sale","acquired":false,"shares":4529,"price":31.9308,"value":144614.5932,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $31.82 to $32.21. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":275878,"source":{"system":"sec-edgar","filing":"0000950103-19-013788","document":"dp114194_4-moll.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319013788/dp114194_4-moll.xml","form_type":"4"}},{"id":3395418,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-09T22:19:37.000Z","date":"2019-10-07","kind":"sale","acquired":false,"shares":10471,"price":31.4896,"value":329727.6016,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 9/6/2019."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. The reported securities were sold in multiple transactions at prices ranging from $30.82 to $31.81. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range."}],"balance_after":280407,"source":{"system":"sec-edgar","filing":"0000950103-19-013788","document":"dp114194_4-moll.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319013788/dp114194_4-moll.xml","form_type":"4"}},{"id":3431056,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Unsecured Subordinated Convertible Promissory Note","published_at":"2019-08-22T23:19:19.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"price":2000000,"reported_value":2000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The promissory note will convert upon the consummation of the transactions contemplated in that certain Agreement and Plan of Merger and Reorganization dated March 15, 2019, among the Issuer, Radiant Merger Sub Ltd., an entity organized under the laws of Israel and Venus Concept Ltd., an entity organized under the laws of Israel."}],"derivative":{"exercise_price":0.4664,"expiration_date":"2020-08-28","underlying":"Common Stock","underlying_shares":4288164},"source":{"system":"sec-edgar","filing":"0001567619-19-017499","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000156761919017499/doc1.xml","form_type":"4"}},{"id":3431055,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Unsecured Subordinated Convertible Promissory Note","published_at":"2019-08-22T23:19:19.000Z","date":"2019-08-20","kind":"purchase","acquired":true,"price":3000000,"reported_value":3000000,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The promissory note will convert upon the consummation of the transactions contemplated in that certain Agreement and Plan of Merger and Reorganization dated March 15, 2019, among the Issuer, Radiant Merger Sub Ltd., an entity organized under the laws of Israel and Venus Concept Ltd., an entity organized under the laws of Israel."}],"derivative":{"exercise_price":0.4664,"expiration_date":"2020-08-28","underlying":"Common Stock","underlying_shares":6432246},"source":{"system":"sec-edgar","filing":"0001567619-19-017499","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000156761919017499/doc1.xml","form_type":"4"}},{"id":3498753,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-06T18:10:53.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":5172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 4, 2019."}],"balance_after":5172,"derivative":{"exercise_price":23.02,"expiration_date":"2029-06-03","underlying":"Common Stock","underlying_shares":5172},"source":{"system":"sec-edgar","filing":"0001562180-19-003399","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019003399/primarydocument.xml","form_type":"4"}},{"id":3498752,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-06T18:10:53.000Z","date":"2019-06-04","kind":"grant","acquired":true,"shares":2312,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan.  Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting.  The restricted stock units vest one year from grant date on June 4, 2020."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 2,312 restricted stock units."}],"balance_after":243450,"source":{"system":"sec-edgar","filing":"0001562180-19-003399","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019003399/primarydocument.xml","form_type":"4"}},{"id":3596893,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Convertible Preferred Stock","published_at":"2019-03-13T20:29:36.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":24347,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":24347},"source":{"system":"sec-edgar","filing":"0000950103-19-003372","document":"dp103686_4-moll.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003372/dp103686_4-moll.xml","form_type":"4"}},{"id":3596892,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Convertible Preferred Stock","published_at":"2019-03-13T20:29:36.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":28767,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":28767},"source":{"system":"sec-edgar","filing":"0000950103-19-003372","document":"dp103686_4-moll.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003372/dp103686_4-moll.xml","form_type":"4"}},{"id":3596891,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A-1 Convertible Preferred Stock","published_at":"2019-03-13T20:29:36.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":114107,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":114107},"source":{"system":"sec-edgar","filing":"0000950103-19-003372","document":"dp103686_4-moll.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003372/dp103686_4-moll.xml","form_type":"4"}},{"id":3596890,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Convertible Preferred Stock","published_at":"2019-03-13T20:29:36.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":123657,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":123657},"source":{"system":"sec-edgar","filing":"0000950103-19-003372","document":"dp103686_4-moll.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003372/dp103686_4-moll.xml","form_type":"4"}},{"id":3596889,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-13T20:29:36.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":24347,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."}],"balance_after":290878,"source":{"system":"sec-edgar","filing":"0000950103-19-003372","document":"dp103686_4-moll.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003372/dp103686_4-moll.xml","form_type":"4"}},{"id":3596888,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-13T20:29:36.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":28767,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."}],"balance_after":266531,"source":{"system":"sec-edgar","filing":"0000950103-19-003372","document":"dp103686_4-moll.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003372/dp103686_4-moll.xml","form_type":"4"}},{"id":3596887,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-13T20:29:36.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":114107,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."}],"balance_after":237764,"source":{"system":"sec-edgar","filing":"0000950103-19-003372","document":"dp103686_4-moll.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003372/dp103686_4-moll.xml","form_type":"4"}},{"id":3596886,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-03-13T20:29:36.000Z","date":"2019-03-11","kind":"exercise","acquired":true,"shares":123657,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share the convertible preferred stock automatically converted into shares of Common Stock on a one-for-one basis immediately upon the closing of the Issuer's initial public offering without payment or consideration. The shares of the convertible preferred stock had no expiration date."}],"balance_after":123657,"source":{"system":"sec-edgar","filing":"0000950103-19-003372","document":"dp103686_4-moll.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003372/dp103686_4-moll.xml","form_type":"4"}},{"id":3603880,"issuer":{"id":90374,"kind":"organization","name":"Shockwave Medical, Inc.","symbol":"SWAV"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to Buy)","published_at":"2019-03-08T21:45:58.000Z","date":"2019-03-06","kind":"grant","acquired":true,"shares":17381,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"1/3rd of the options shall vest each year beginning on March 11, 2020 until 100% of the options have vested."}],"balance_after":17381,"derivative":{"exercise_price":17,"expiration_date":"2029-03-06","underlying":"Common Stock","underlying_shares":17381},"source":{"system":"sec-edgar","filing":"0000950103-19-003227","document":"dp103551_4-moll.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1260157/000095010319003227/dp103551_4-moll.xml","form_type":"4"}},{"id":3691684,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-01-18T17:36:41.000Z","date":"2019-01-16","kind":"grant","acquired":true,"shares":3220,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments commencing on January 1, 2019."}],"balance_after":3220,"derivative":{"exercise_price":28.58,"expiration_date":"2029-01-15","underlying":"Common Stock","underlying_shares":3220},"source":{"system":"sec-edgar","filing":"0001562180-19-000369","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218019000369/primarydocument.xml","form_type":"4"}},{"id":3846119,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-08-13T22:18:36.000Z","date":"2018-08-09","kind":"purchase","acquired":true,"shares":333333,"price":1.5,"value":499999.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares were acquired in connection with an underwritten public offering of common stock which closed on August 14, 2018."}],"balance_after":929809,"source":{"system":"sec-edgar","filing":"0001567619-18-000663","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000156761918000663/doc1.xml","form_type":"4"}},{"id":3892354,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-15T20:07:14.000Z","date":"2018-06-13","kind":"grant","acquired":true,"shares":13708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option will vest in full on the earlier of (A) June 13, 2019 or (B) immediately prior to the next annual meeting of the Company's stockholders, subject to continued service on the board of directors through each applicable vesting date."}],"balance_after":13708,"derivative":{"exercise_price":2.89,"expiration_date":"2028-06-13","underlying":"Common Stock","underlying_shares":13708},"source":{"system":"sec-edgar","filing":"0000899243-18-016757","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000089924318016757/doc4.xml","form_type":"4"}},{"id":3901413,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2018-06-07T17:20:01.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":3473,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 5, 2018."}],"balance_after":3473,"derivative":{"exercise_price":42.05,"expiration_date":"2028-06-04","underlying":"Common Stock","underlying_shares":3473},"source":{"system":"sec-edgar","filing":"0001562180-18-002918","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018002918/primarydocument.xml","form_type":"4"}},{"id":3901412,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-07T17:20:01.000Z","date":"2018-06-05","kind":"grant","acquired":true,"shares":1514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan.  Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting.  The restricted stock units vest one year from grant date on June 5, 2019."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 1,514 RSUs."}],"balance_after":241138,"source":{"system":"sec-edgar","filing":"0001562180-18-002918","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018002918/primarydocument.xml","form_type":"4"}},{"id":4094444,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2018-01-19T17:17:34.000Z","date":"2018-01-17","kind":"grant","acquired":true,"shares":2797,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option vest in 12 equal monthly installments commencing on January 1, 2018."}],"balance_after":2797,"derivative":{"exercise_price":33.95,"expiration_date":"2028-01-16","underlying":"Common Stock","underlying_shares":2797},"source":{"system":"sec-edgar","filing":"0001562180-18-000369","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218018000369/primarydocument.xml","form_type":"4"}},{"id":4156146,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-20T17:37:46.000Z","date":"2017-11-20","kind":"sale","acquired":false,"shares":2500,"price":28.758,"value":71895.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $28.75 to $28.80, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4."}],"balance_after":239624,"source":{"system":"sec-edgar","filing":"0001562180-17-003642","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218017003642/primarydocument.xml","form_type":"4"}},{"id":4156145,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-20T17:37:46.000Z","date":"2017-11-17","kind":"sale","acquired":false,"shares":5000,"price":28.7415,"value":143707.5,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $28.60 to $28.90, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4."}],"balance_after":242124,"source":{"system":"sec-edgar","filing":"0001562180-17-003642","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218017003642/primarydocument.xml","form_type":"4"}},{"id":4156144,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-20T17:37:46.000Z","date":"2017-11-16","kind":"sale","acquired":false,"shares":6700,"price":28.7707,"value":192763.69,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $28.50 to $29.05, inclusive.  The Reporting Person undertakes to provide, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote on this Form 4."}],"balance_after":247124,"source":{"system":"sec-edgar","filing":"0001562180-17-003642","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218017003642/primarydocument.xml","form_type":"4"}},{"id":4163497,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-11-14T18:01:31.000Z","date":"2017-11-10","kind":"sale","acquired":false,"shares":800,"price":29,"value":23200.0,"ownership":{"direct":true},"balance_after":253824,"source":{"system":"sec-edgar","filing":"0001562180-17-003559","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218017003559/primarydocument.xml","form_type":"4"}},{"id":4184746,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series C Preferred Stock","published_at":"2017-10-17T22:37:37.000Z","date":"2017-10-16","kind":"exercise","acquired":false,"shares":46620,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":46620},"source":{"system":"sec-edgar","filing":"0001140361-17-038915","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038915/doc1.xml","form_type":"4"}},{"id":4184745,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2017-10-17T22:37:37.000Z","date":"2017-10-16","kind":"exercise","acquired":false,"shares":153846,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":153846},"source":{"system":"sec-edgar","filing":"0001140361-17-038915","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038915/doc1.xml","form_type":"4"}},{"id":4184744,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series A Preferred Stock","published_at":"2017-10-17T22:37:37.000Z","date":"2017-10-16","kind":"exercise","acquired":false,"shares":316725,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The expiration date is not relevant to the conversion of these securities."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":316725},"source":{"system":"sec-edgar","filing":"0001140361-17-038915","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038915/doc1.xml","form_type":"4"}},{"id":4184743,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-17T22:37:37.000Z","date":"2017-10-16","kind":"exercise","acquired":true,"shares":46620,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."}],"balance_after":596476,"source":{"system":"sec-edgar","filing":"0001140361-17-038915","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038915/doc1.xml","form_type":"4"}},{"id":4184742,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-17T22:37:37.000Z","date":"2017-10-16","kind":"exercise","acquired":true,"shares":153846,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."}],"balance_after":549856,"source":{"system":"sec-edgar","filing":"0001140361-17-038915","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038915/doc1.xml","form_type":"4"}},{"id":4184741,"issuer":{"id":55304,"kind":"organization","name":"Venus Concept Inc.","symbol":"VERO"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-17T22:37:37.000Z","date":"2017-10-16","kind":"exercise","acquired":true,"shares":316725,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of the Issuer's Preferred Stock automatically converted into shares of the Issuer's Common Stock, for no additional consideration, on a 1:1 basis immediately prior to the consummation of the Issuer's Initial Public Offering."}],"balance_after":396010,"source":{"system":"sec-edgar","filing":"0001140361-17-038915","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1409269/000114036117038915/doc1.xml","form_type":"4"}},{"id":4268197,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series D Participating Convertible Preferred Stock","published_at":"2017-07-03T17:48:01.000Z","date":"2017-06-30","kind":"exercise","acquired":false,"shares":1921,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"These shares of Series D Participating Convertible Preferred Stock (\"Preferred Stock\") were acquired by Frederic H. Moll in a private placement with the Issuer, which closed on April 18, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The Preferred Stock had no expiration date."}],"balance_after":0,"derivative":{"exercise_price":1.24,"exercise_date":"2017-06-30","underlying":"Common Stock","underlying_shares":192100},"source":{"system":"sec-edgar","filing":"0001209191-17-042884","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117042884/doc4.xml","form_type":"4"}},{"id":4268196,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-07-03T17:48:01.000Z","date":"2017-06-30","kind":"exercise","acquired":true,"shares":192100,"price":1.24,"value":238204.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On June 30, 2017, as a result of receipt of the Requisite Stockholder Approval (defined and described further in the Securities Purchase\nAgreement dated April 11, 2017 and filed as Exhibit 99.1 to the Current Report on Form 8-K filed by the Issuer on April 14, 2017), each share of\nPreferred Stock (as defined below) automatically converted into 100 shares of Common Stock, reflecting a conversion price equal to $1.24 per\nshare."}],"balance_after":251317,"source":{"system":"sec-edgar","filing":"0001209191-17-042884","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117042884/doc4.xml","form_type":"4"}},{"id":4292630,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Options (Right to buy)","published_at":"2017-06-05T19:29:34.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":6035,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The shares subject to the option vest in 12 equal monthly installments commencing on June 1, 2017."}],"balance_after":6035,"derivative":{"exercise_price":26.05,"expiration_date":"2027-05-31","underlying":"Common Stock","underlying_shares":6035},"source":{"system":"sec-edgar","filing":"0001562180-17-002199","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218017002199/primarydocument.xml","form_type":"4"}},{"id":4292629,"issuer":{"id":127294,"kind":"organization","name":"Intersect ENT, Inc.","symbol":"XENT"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-06-05T19:29:34.000Z","date":"2017-06-01","kind":"grant","acquired":true,"shares":2546,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents restricted stock units granted pursuant to the Intersect ENT, Inc. 2014 Equity Incentive Plan.  Each restricted stock unit represents a right to receive one share of Intersect ENT, Inc. common stock upon vesting.  The restricted stock units vest one year from grant date on June 1, 2018."}],"balance_after":254624,"source":{"system":"sec-edgar","filing":"0001562180-17-002199","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1271214/000156218017002199/primarydocument.xml","form_type":"4"}},{"id":4323929,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2017-05-12T16:10:43.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":35211,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents the right to receive, at settlement, one share of common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock unit award fully vests and is immediately exercisable on the first anniversary of the date of the award."}],"balance_after":35211,"derivative":{"underlying":"Common Stock","underlying_shares":35211},"source":{"system":"sec-edgar","filing":"0001209191-17-031900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117031900/doc4.xml","form_type":"4"}},{"id":4323928,"issuer":{"id":11470,"kind":"organization","name":"BIOLASE, INC","symbol":"BIOL"},"owners":[{"id":17739,"kind":"person","name":"MOLL FREDERIC H","position":1,"cik":"0001260157","reported_name":"MOLL FREDERIC H","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-12T16:10:43.000Z","date":"2017-05-10","kind":"grant","acquired":true,"shares":105634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests and is exercisable in equal monthly installments over a consecutive 12-month period, commencing one month from the date of grant."}],"balance_after":456623,"derivative":{"exercise_price":1.21,"expiration_date":"2027-05-10","underlying":"Common Stock","underlying_shares":105634},"source":{"system":"sec-edgar","filing":"0001209191-17-031900","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/811240/000120919117031900/doc4.xml","form_type":"4"}}],"next_cursor":"2017-05-12T16:10:43.000000Z,4323928"}